Blog

Brave Bison Group PLC (LSE:BBSN) has launched an increased final takeover offer for System1 Group PLC (LSE:SYS1), valuing the consideration at an implied 405 pence per System1 share, excluding the potential value of a contingent value right (CVR).

The proposed acquisition targets approximately 72% of System1’s issued share capital that Brave Bison does not already own. The consideration comprises a combination of cash, newly issued Brave Bison shares and a contingent value right.

As of 15 October 2026, Brave Bison reported that its existing shareholding, valid offer acceptances, irrevocable undertakings and letters of intent collectively represented approximately 39.67% of System1’s issued share capital.

However, the company said approximately 27.96% of System1 shares could currently be counted towards satisfying the offer’s acceptance condition.

Brave Bison has called on remaining System1 shareholders to accept the offer by 26 October 2026.

Increased Final Offer Includes Cash, Shares and Contingent Value Right

Brave Bison’s revised proposal combines three forms of consideration for System1 shareholders.

The offer includes a cash component, newly issued Brave Bison ordinary shares and a contingent value right that may provide additional consideration depending on its terms.

The implied value of 405 pence per System1 share excludes any potential payment associated with the CVR.

The final amount received by accepting shareholders may therefore depend on the value of the share consideration and whether the conditions associated with the contingent value right are satisfied.

The increased offer forms part of Brave Bison’s proposed acquisition of the remaining System1 shares it does not already own.

The transaction would combine Brave Bison’s digital media and marketing services operations with System1’s advertising research and effectiveness measurement activities.

Brave Bison Reports 39.67% Combined Shareholder Position

Brave Bison provided an update on its position in System1 as of 15 October 2026, reporting that its existing ownership, valid acceptances, irrevocable undertakings and letters of intent together accounted for approximately 39.67% of the target company’s issued share capital.

The figure includes different categories of shareholder support and ownership, which do not all carry the same status under the takeover process.

Brave Bison said approximately 27.96% of System1’s issued shares could currently be counted towards satisfying the acceptance condition.

The distinction is relevant because irrevocable undertakings and letters of intent do not necessarily constitute valid acceptances of the offer.

The company is seeking further acceptances from System1 shareholders ahead of the 26 October deadline.

The announcement does not confirm that the acceptance condition has been satisfied or that the acquisition has completed.

Shareholders Face 26 October Acceptance Deadline

Brave Bison has identified 26 October 2026 as the deadline for remaining System1 shareholders to accept its increased final offer.

Shareholders considering the proposal will need to assess the cash and share consideration alongside the terms of the contingent value right.

The offer remains subject to its applicable conditions, including the required level of shareholder acceptances.

Although Brave Bison has reported ownership and shareholder support covering approximately 39.67% of System1’s issued share capital, the proportion currently eligible to count towards the acceptance condition is lower, at approximately 27.96%.

Further valid acceptances would increase the proportion of shares counted towards that condition.

The company has not confirmed that all conditions required to complete the proposed acquisition have been met.

Proposed Acquisition Would Combine Digital Marketing and Advertising Research Businesses

Brave Bison operates in digital media, online video, social media and advertising services, providing marketing-related solutions to brands and agencies.

System1 specialises in advertising effectiveness research, brand growth consultancy and marketing analytics.

Its services include research and testing platforms designed to assess advertising content and provide information on campaign effectiveness.

Brave Bison’s proposed acquisition would bring System1’s research and analytics capabilities into its existing digital marketing operations.

The transaction is consistent with Brave Bison’s acquisition-led strategy of expanding its content, data and technology services.

Completion of the proposed combination remains dependent on the takeover process and satisfaction of the relevant offer conditions.

About Brave Bison and System1

Brave Bison Group PLC (LSE:BBSN) is a digital media and marketing services company operating across online video, social media, advertising and related technology services.

The company has pursued acquisitions as part of its strategy to expand its marketing capabilities and client services in the United Kingdom and international markets.

System1 Group PLC (LSE:SYS1) is a marketing research and analytics company specialising in advertising effectiveness, brand measurement and consultancy services.

System1 provides research tools and advertising testing services to corporate customers seeking to evaluate marketing content and campaign performance.

Man Group plc (LSE:EMG) reported an increase in assets under management (AUM) to $270.9 billion at 30 September 2026, compared with $253.6 billion at the end of the previous quarter, supported by net client inflows and positive investment performance.

The FTSE 250-listed investment management company recorded net inflows of $10.1 billion during the third quarter, alongside a $5.9 billion contribution from investment performance.

Assets under management increased by $17.3 billion over the period, with growth across several investment categories, including liquid alternatives and long-only equities.

The company also reported generally positive investment performance across key strategies in liquid alternatives, long-only equity and credit during the first nine months of 2026.

Net Inflows and Investment Performance Support AUM Growth

Man Group’s assets under management increased from $253.6 billion to $270.9 billion during the three months ended 30 September 2026.

Net inflows contributed $10.1 billion to the quarterly movement, while investment performance added $5.9 billion.

Together, these factors accounted for $16.0 billion of the increase, with the remaining $1.3 billion reflecting other movements not detailed in the supplied trading update.

The inflows indicate that client subscriptions exceeded withdrawals during the quarter, while the positive investment performance contribution reflected changes in the value of assets managed by the group.

Man Group operates investment strategies across public and private markets, providing systematic, discretionary and tailored investment solutions to institutional and other sophisticated investors.

Liquid Alternatives AUM Reaches $99.7 Billion

Assets under management in Man Group’s liquid alternatives business increased to $99.7 billion at the end of September.

The category includes alternative investment strategies designed to operate within liquid financial markets, using approaches such as systematic trading, risk premia and multi-strategy investment management.

Liquid alternatives were among the principal contributors to the group’s overall AUM expansion during the third quarter.

The company has continued developing its range of alternative investment products, including solutions-based strategies and risk premia offerings.

These activities form part of Man Group’s investment management platform, which combines quantitative techniques, technology and portfolio management expertise.

Long-Only Equity Assets Increase to $113.2 Billion

Man Group’s long-only equity business also recorded growth, with assets under management reaching $113.2 billion at 30 September 2026.

The company offers long-only equity strategies using systematic and other investment approaches across public markets.

Growth in this category contributed to the increase in group assets under management during the quarter.

The firm’s private markets business, meanwhile, remained broadly stable over the reporting period.

Across the first nine months of 2026, Man Group reported generally positive performance from key investment strategies spanning liquid alternatives, long-only equity and credit.

The supplied update does not provide individual performance percentages for these strategies.

Investment Platform Includes Systematic and Solutions-Based Strategies

Man Group continues to develop investment products across its systematic, discretionary and solutions-based businesses.

Its investment platform includes risk premia strategies, systematic long-only equities and multi-manager investment solutions, alongside credit and private market offerings.

The company uses technology and quantitative research in the development and management of several of its investment strategies.

Its solutions business provides investment arrangements designed around specific client requirements, while its broader platform offers both single-strategy and multi-strategy products.

The increase in assets under management expands the amount of client capital managed by the group, although the effect on management fee revenue will depend on the fee structures and product mix associated with those assets.

The third-quarter update does not include revised revenue or profit guidance.

Man Group Reports Growth Across Public Market Strategies

The quarterly figures show that Man Group’s AUM expansion was supported by both client capital flows and investment returns.

Liquid alternatives and long-only equities accounted for substantial portions of the group’s assets under management at the end of September, while private markets remained comparatively unchanged.

The company continues to operate across different investment categories, with its business model incorporating systematic trading, discretionary portfolio management and tailored investment solutions.

Man Group’s reported AUM of $270.9 billion represents its asset base at the end of the third quarter of 2026.

About Man Group plc

Man Group plc (LSE:EMG) is a global investment management company headquartered in Jersey and listed on the London Stock Exchange.

The FTSE 250 constituent provides systematic, discretionary and solutions-based investment strategies across public and private markets.

Its investment platform covers liquid alternatives, long-only equities, credit, private markets and multi-manager solutions.

The company manages capital on behalf of institutional investors and other clients, using quantitative research, technology and portfolio management capabilities across its investment businesses.

Europa Oil & Gas (Holdings) plc (LSE:EOG) has secured a 12-month extension to the first exploration sub-period of its EG-08 production sharing contract (PSC) in Equatorial Guinea, extending the deadline to 4 October 2027.

The AIM-listed oil and gas exploration company said the extension was approved by Equatorial Guinea’s Ministry of Hydrocarbons and Mining Development, which confirmed that the contractor had fulfilled its obligations under the agreement to date.

The additional time will allow Europa and its partners to continue negotiations over a proposed farm-out agreement with Fuhai and progress preparations for the Barracuda exploration well, which is currently expected to be drilled during the first half of 2027.

Europa estimates that the EG-08 licence contains approximately 2.2 trillion cubic feet (TCF) of gross prospective gas resources, including an estimated 878 billion cubic feet (BCF) associated with the Barracuda prospect.

EG-08 Exploration Deadline Extended to October 2027

The extension moves the end of the first exploration sub-period under Phase 1 of the EG-08 production sharing contract to 4 October 2027.

Europa said the Ministry of Hydrocarbons and Mining Development had confirmed that the contractor had met its contractual obligations to date.

The decision allows exploration activities to continue under the existing PSC framework while the company and its partners advance their plans for the licence.

The extension provides additional time for commercial arrangements and operational preparations associated with the proposed Barracuda drilling programme.

The announcement does not indicate any changes to the licence’s prospective resource estimates or specify additional exploration commitments arising from the extension.

Barracuda Exploration Well Targeted for First Half of 2027

Europa and its partners are preparing to drill the Barracuda exploration well within the EG-08 licence area.

The company currently expects drilling to take place during the first half of 2027, although the programme remains subject to the completion of relevant preparations and commercial arrangements.

Barracuda is estimated by Europa to contain 878 BCF of gross prospective gas resources.

The proposed well is intended to investigate the presence of hydrocarbons within the prospect and provide geological information relevant to its resource potential.

The prospective resource estimate represents an assessment of potentially recoverable gas volumes from an undrilled prospect rather than confirmed reserves.

Actual hydrocarbon volumes, if discovered, will depend on the results of drilling and subsequent technical evaluation.

Europa Continues Farm-Out Discussions With Fuhai

The licence extension also provides additional time for Europa and its partners to finalise a proposed farm-out agreement with Fuhai.

A farm-out arrangement typically involves the transfer of an interest in an exploration asset to another participant in exchange for agreed commercial consideration or funding commitments.

Europa has identified the completion of the proposed agreement as part of its preparations for advancing exploration at EG-08.

The company has not disclosed final commercial terms or confirmed that the proposed transaction has been completed.

The discussions are taking place alongside preparations for the Barracuda well, with Europa continuing to work with its project partners, including state-owned GEPetrol.

EG-08 Contains Estimated 2.2 TCF of Gross Prospective Gas Resources

Europa’s internal assessment attributes approximately 2.2 TCF of gross prospective gas resources to the EG-08 licence.

Within that total, the Barracuda prospect accounts for an estimated 878 BCF.

These figures represent prospective resources rather than discovered gas volumes or commercially recoverable reserves.

The planned exploration well will provide information to help assess the presence and extent of gas within the Barracuda structure.

Further exploration, appraisal and technical work would be required before any discovery could be evaluated for potential commercial development.

The EG-08 project forms part of Europa’s wider portfolio of upstream oil and gas interests across West Africa, the United Kingdom and Ireland.

About Europa Oil & Gas

Europa Oil & Gas (Holdings) plc (LSE:EOG) is an AIM-listed oil and gas exploration, development and production company with interests in West Africa, the United Kingdom and Ireland.

The company participates in upstream energy projects through licence interests and production sharing contracts, including the EG-08 exploration licence in Equatorial Guinea.

Its activities include evaluating prospective hydrocarbon resources, progressing exploration programmes and working with partners on potential project development.

Greatland Resources (LSE:GGP) has granted 774,272 long-term incentive performance rights to employees under its FY27 equity incentive plan, including awards to Chief Operating Officer Nickolas Strong and Chief Financial Officer Monique Connolly.

The gold and copper mining company said the awards provide eligible employees with rights to receive ordinary shares, subject to vesting and exercise conditions linked to continued service and performance over a three-year period.

The performance period runs from 1 July 2026 to 30 June 2029, with achievement against the relevant targets to be assessed at the end of the 2029 financial year.

The company has also disclosed awards to persons discharging managerial responsibilities (PDMRs) in accordance with UK Market Abuse Regulation requirements.

Performance Rights Linked to Shareholder Returns and Mineral Resources

Greatland’s FY27 long-term incentive awards are subject to performance conditions covering shareholder returns and the development of the company’s mineral resource and reserve base.

The three-year performance framework includes relative total shareholder return (TSR), assessed against an index and a designated peer group.

Total shareholder return measures investment performance through changes in share price and distributions to shareholders over the assessment period.

Additional performance conditions relate to growth in mineral resources and reserves, reflecting the company’s operational focus on its gold and copper assets in Western Australia.

The different performance measures carry specified weightings within the incentive plan, although the supplied announcement does not provide the individual percentage allocations.

Vesting will depend on the achievement of the applicable performance hurdles and satisfaction of service conditions.

Awards Include Chief Operating Officer and Chief Financial Officer

The 774,272 performance rights granted under the FY27 plan include allocations to Chief Operating Officer Nickolas Strong and Chief Financial Officer Monique Connolly.

The awards form part of Greatland’s equity-based remuneration arrangements for employees and senior management.

Under the plan, participants may become entitled to ordinary shares if the relevant vesting requirements are satisfied and the rights are exercised.

The company has disclosed the awards made to its PDMRs, including information concerning the number of rights, grant date and applicable terms.

The disclosures are intended to meet regulatory requirements governing transactions and remuneration arrangements involving senior executives of listed companies.

The announcement does not specify the individual allocations to Strong and Connolly in the supplied material.

Havieron Project Delivery Included in Managing Director Incentives

Greatland’s incentive arrangements also include a performance condition linked to delivery of the Havieron gold-copper development project.

This condition applies to the managing director’s incentive arrangements and remains subject to shareholder approval.

Havieron is located in Western Australia’s Paterson Province, adjacent to Greatland’s Telfer mining operation.

The project forms part of the company’s plans to develop its gold and copper production assets in the region.

The inclusion of a Havieron delivery condition introduces a project-specific performance measure alongside the broader shareholder return and mineral resource targets used in the incentive framework.

Any awards subject to shareholder approval will depend on the relevant approval being obtained.

Equity Awards May Result in Additional Ordinary Shares

The performance rights represent potential future entitlements to ordinary shares rather than immediate allocations of shares.

The number of rights that ultimately vest will depend on the applicable service requirements and performance outcomes over the three-year assessment period.

Where rights vest and are exercised through the issue of new shares, the awards could increase Greatland’s issued share capital and dilute existing shareholders’ percentage ownership.

The actual impact will depend on the number of rights that vest and the method used to satisfy the awards.

The performance conditions will be assessed following the conclusion of the period ending 30 June 2029.

Greatland Continues Development of Telfer and Havieron Assets

Greatland operates a portfolio of gold and copper assets in Western Australia, including the wholly owned Telfer mine and the adjacent Havieron development project.

Telfer is an established mining operation, while Havieron represents a development asset within the same regional mining area.

The company’s activities also include exploration across the Paterson Province, where it is evaluating opportunities to expand its mineral resource and reserve base.

Growth in resources and reserves is one of the measures incorporated into the FY27 performance rights programme.

Greatland’s operational strategy includes managing production at Telfer, advancing Havieron and undertaking exploration activities across its regional portfolio.

About Greatland Resources

Greatland Resources (LSE:GGP) is a gold and copper mining company with operations and development projects in Western Australia.

The company is listed on the Australian Securities Exchange and London’s AIM market.

Its principal assets include the 100%-owned Telfer gold-copper mine and the neighbouring Havieron development project in the Paterson Province.

Greatland also holds regional exploration interests and focuses on mineral resource development, mining operations and the advancement of its gold and copper project portfolio.

IP Group plc (LSE:IPO) has invested £4 million in portfolio company Microbiotica as part of a £36 million Series C financing round intended to support the clinical development of microbiome-based treatments.

The London-listed science and technology investment company said the financing increases its undiluted beneficial ownership interest in Microbiotica to 16.4%, with the holding valued at £24.1 million.

The funding round was led by British Business Bank, with participation from Tencent and other existing investors.

Microbiotica intends to use the proceeds primarily to advance its lead oral microbiome therapy, MB310, into Phase 2 clinical development for ulcerative colitis, following results from an earlier Phase 1b study.

Microbiotica Raises £36 Million to Advance Clinical Development

Microbiotica, a privately held biopharmaceutical company specialising in microbiome-based medicines, has completed a £36 million Series C financing round.

The investment will principally support the next stage of clinical development for MB310, an orally administered treatment candidate being investigated for ulcerative colitis.

The company previously reported positive results from a Phase 1b clinical study, providing the basis for progressing the treatment candidate into Phase 2 development.

The planned Phase 2 programme will represent a further stage of clinical evaluation, although the supplied announcement does not specify the trial’s anticipated start date, patient enrolment targets or expected completion timetable.

Microbiotica is also developing microbiome-based treatments for immuno-oncology applications as part of its broader clinical pipeline.

IP Group Increases Microbiotica Ownership to 16.4%

IP Group participated in the Series C financing with a £4 million investment, increasing its undiluted beneficial stake in Microbiotica to 16.4%.

The company reported a valuation of £24.1 million for its holding following the financing.

The investment forms part of IP Group’s portfolio activities in healthcare and life sciences, where it provides capital to businesses developing technologies originating from scientific research.

British Business Bank led the funding round, while Tencent and other existing shareholders also participated.

The transaction provides Microbiotica with additional funding for its clinical development programme and increases IP Group’s ownership exposure to the privately held company.

MB310 Targets Ulcerative Colitis

Microbiotica’s lead development programme, MB310, is an oral microbiome therapy being investigated as a potential treatment for ulcerative colitis.

The candidate belongs to a class of treatments known as live biotherapeutic products, which use selected microorganisms for therapeutic purposes.

Microbiotica develops its treatment candidates using a proprietary genomics-driven platform designed to analyse the human microbiome and identify microbial combinations for potential medical applications.

The company’s approach involves using microbiome profiling and genomic information to develop targeted therapies for specific conditions.

Following the Phase 1b results, Microbiotica plans to evaluate MB310 further through Phase 2 clinical development.

The treatment remains investigational, and additional clinical studies will be required to assess its efficacy and safety.

Investment Supports IP Group’s Life Sciences Portfolio

IP Group invests in science and technology businesses across healthcare, deep technology and clean technology.

Its portfolio includes companies developing products and technologies based on research originating from universities and other scientific institutions.

Microbiotica was established as a spinout from the Wellcome Sanger Institute and is based at Chesterford Research Park near Cambridge.

The company focuses on precision microbiome medicines, including treatments for inflammatory bowel disease and potential applications in cancer treatment.

IP Group’s additional £4 million investment increases its financial interest in Microbiotica as the biopharmaceutical company prepares for the next phase of clinical testing.

The reported £24.1 million valuation of IP Group’s holding reflects its investment position following the Series C financing.

About IP Group plc

IP Group plc (LSE:IPO) is a London-listed investment company focused on science and technology businesses operating in healthtech, deeptech and cleantech.

The group invests directly in companies developing research-based technologies and also operates through its Parkwalk growth Enterprise Investment Scheme funds.

Its investment activities include businesses emerging from universities and research institutions, with portfolio companies including Oxford Nanopore Technologies and Hinge Health.

IP Group provides capital to businesses at different stages of development, including companies progressing technologies through research, clinical evaluation and commercialisation.

Greencoat UK Wind (LSE:UKW) has announced plans to host a live investor presentation on 27 October 2026 through the Investor Meet Company platform, providing an update on its investment strategy and opportunities within the UK wind energy sector.

The presentation will be led by Matt Ridley and Stephen Packwood and follows the company’s recent Capital Markets Event.

The session will focus on how Greencoat UK Wind intends to use its existing business model, portfolio scale and internally generated capital to pursue a broader range of investment opportunities in UK wind power assets.

The company said its approach is intended to support long-term shareholder returns through continued investment in renewable energy infrastructure.

Presentation to Cover UK Wind Investment Opportunities

Greencoat UK Wind’s forthcoming presentation will provide investors with further information about its strategy for developing its portfolio of UK wind energy investments.

The company intends to build on its existing investment model by using the scale of its operations and capital generated internally to access additional investment opportunities.

The strategy involves evaluating a broader range of potential investments within the UK wind sector while maintaining the company’s focus on long-term shareholder returns.

The presentation follows the recent Capital Markets Event, during which Greencoat UK Wind outlined its approach to future investment activity.

The 27 October session will provide an additional opportunity for investors to hear about the company’s plans and discuss its investment priorities.

Investors Invited to Submit Questions

The presentation will take place through Investor Meet Company, an online platform used by listed companies to communicate with existing and prospective shareholders.

Greencoat UK Wind has confirmed that the event will be open to both current investors and individuals considering an investment in the company.

Participants will be able to submit questions through the platform’s dashboard before the presentation or during the live session.

Matt Ridley and Stephen Packwood will lead the discussion, covering the company’s investment approach and plans for accessing opportunities within the UK wind energy market.

The announcement does not specify any new acquisitions, financing arrangements or changes to the company’s existing investment policy.

Portfolio Scale and Internally Generated Capital Form Part of Strategy

Greencoat UK Wind invests in renewable electricity generation assets across the United Kingdom, with its portfolio focused on wind power infrastructure.

The company has identified its existing scale and internally generated capital as factors supporting its ability to evaluate additional investment opportunities.

Its investment approach centres on acquiring and holding wind energy assets that generate electricity and provide financial returns over time.

The forthcoming presentation will explain how the company intends to apply this model to a broader range of UK wind investments.

Greencoat UK Wind’s stated objective remains the delivery of long-term shareholder returns through investment in renewable energy infrastructure.

About Greencoat UK Wind

Greencoat UK Wind (LSE:UKW) is a London-listed renewable infrastructure investment company focused on UK wind power assets.

The company invests in wind energy projects and seeks to generate long-term shareholder returns from its renewable electricity generation portfolio.

Its investment strategy includes using portfolio scale and internally generated capital to assess additional opportunities in the UK wind sector.